Device type · DKZ
Enzyme Immunoassay, Amphetamine
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DKZ
Clinical Toxicology
Device class
Class II
FDA decisions since 2015
20
510(k), De Novo and PMA
Adverse event reports
4
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Enzyme Immunoassay, Amphetamine
- Product code
- DKZ
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3100
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DKZ
Latest FDA decisions
The 8 newest of 20 since 2015.
- DRI Ecstasy Plus Assay510(k)
K240670 · Decided Oct 30, 2024 · 233 days after receipt
Device type: Enzyme Immunoassay, Amphetamine (DKZ) · Laboratory Medicine & Pathology
Hangzhou AllTest Biotech Co., Ltd.
K233019 · Decided Dec 13, 2023 · 82 days after receipt
Device type: Enzyme Immunoassay, Amphetamine (DKZ) · Laboratory Medicine & Pathology
Xenta Biomedical Science Co., Ltd.
K231137 · Decided May 19, 2023 · 28 days after receipt
Device type: Enzyme Immunoassay, Amphetamine (DKZ) · Laboratory Medicine & Pathology
17 more FDA decisions with a free account
Reports received
4
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
3
75% of reports
Injury reports
1
25% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 1 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 1 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Unk1
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect, Inadequate or Imprecise Result or Readings2
- False Positive Result1
- High Test Results1
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions4
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Mckesson Medical-Surgical Inc. Corporate Office
Z-1589-2022 · Started May 25, 2022 · Posted by FDA Aug 26, 2022
Reason given: Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
Cause as FDA categorized it: Environmental control
Z-3048-2020 · Started Aug 18, 2020
Reason given: Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Cause as FDA categorized it: Process control
- First Check 4 Panel Drug Cup: COC/MET1000/OPI2000/THC): (THC/COC); AMT Item Number 990100BTerminated
Z-3049-2020 · Started Aug 18, 2020
Reason given: Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Cause as FDA categorized it: Process control
21 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.